News by subject: Stock Sale/Buyback

Velo3D, Inc. (the "Company"), a leading additive manufacturing technology company for mission-critical metal parts, today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in a...

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company's Board of...

Leading gaming accessory maker Turtle Beach Corporation ("Turtle Beach" or the "Company") announced today its Board of Directors has modified its previously communicated near-term return of capital plan to shareholders, given the overwhelmingly...

Citigroup Inc. is announcing the redemption, in whole, constituting $2,750,000,000 of its 3.352% Fixed Rate / Floating Rate Notes due 2025 (the "notes") (ISIN: US172967MF56). The redemption date for the notes is April 24, 2024 (the "redemption...

Terreno Realty Corporation , an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today its operating, investment and capital markets activity for the first quarter of 2024. Operating As of March...

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that it has entered into definitive agreements for the sale and issuance of 2,272,728 common...

OppFi Inc. ("OppFi" or the "Company"), a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans, today announced that its Board of Directors (the "Board") has...

RMG Acquisition Corp. III (the "Company") today announced that, because the Company will not consummate an initial business combination within the time period required by its Fourth Amended and Restated Memorandum and Articles of Association, the...

Hilton Grand Vacations Inc. announces today the successful re-pricing of its existing $1.3 billion Term Loan B, maturing Aug. 2, 2028. The new pricing will be SOFR plus 250 basis points, down from SOFR plus 275 basis points. Additionally, the credit...

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors granted one...

Visa today commenced its previously announced initial Exchange Offer for any and all outstanding shares of its Class B-1 common stock for a combination of Visa's Class B-2 common stock, Visa's Class C common stock and, where applicable, cash in lieu...

Sila Realty Trust, Inc. (the "Company" or "Sila"), a net lease real estate investment trust ("REIT") with a strategic focus on investing in the significant, growing, and resilient healthcare sector of the U.S. economy, is pleased to announce that...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...

Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,391,832 shares of its common stock at a price to the public of $1.15 per share. In addition, Biodesix...

JBT Corporation , a leading global technology solutions provider to high-value segments of the food & beverage industry, today announced that JBT and Marel hf. (ICL: Marel) have executed a definitive transaction agreement related to JBT's previously...

TD SYNNEX Corporation ("TD SYNNEX" or the "Company") today announced the pricing of the previously announced secondary public offering of 5,309,299 shares of its common stock. All of the shares in the offering are being sold by certain entities...

Cannae Holdings, Inc. ("Cannae" or the "Company") today announced the final results of its modified "Dutch auction" tender offer (the "Offer") to purchase up to $200 million in aggregate purchase price of its outstanding shares of common stock, par...

RiverNorth Capital and Income Fund, Inc. (the "Fund") , a closed-end fund, announced the final results of its repurchase offer for up to 5% of its outstanding common shares. The repurchase offer expired at 5:00 P.M. Eastern Time on April 3, 2024....

CCC Intelligent Solutions Holdings Inc. (the "Company") today announced the proposed secondary offering of 20 million shares of the Company's common stock (the "Offering") by affiliates of Advent International, L.P. and Oak Hill Capital Partners...

TD SYNNEX Corporation ("TD SYNNEX" or the "Company") today announced a proposed secondary public offering of 5,309,299 shares of its common stock currently held by certain entities managed by affiliates of Apollo Global Management, Inc. (the...

Viridian Therapeutics, Inc. (the "company" or "Viridian"), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent...

Bureau Veritas, a global leader in the Testing, Inspection and Certification (TIC) industry, today announces its decision to acquire from Wendel a block of its own shares ? which will amount to a maximum of EUR 100 million and represent circa 0.8% of...

Cartesian Therapeutics, Inc. (the "Company"), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to four new employees. On April 1, 2024,...

Barclays Bank PLC (the "Issuer") announced today that, in connection with its previously announced cash tender offers (each, an "Offer") to purchase any and all of its outstanding exchange-traded notes (the "Notes" or the "ETNs") of the sixteen...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on April 2, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit award covering 7,500 shares of Puma common...

Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 9,000 shares of Astria's common stock on April 1, 2024 under Astria's...

NRG Energy, Inc. announced today that it has entered into separate, privately negotiated transactions with certain holders of its existing 2.75% convertible senior notes due 2048 (the "Convertible Notes") to repurchase approximately $251 million...

Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that on April 1, 2024, the Compensation Committee of Equillium's Board of...

CI Financial Corp. ("CI Financial" or the "Corporation") today announced the preliminary results of its substantial issuer bid (the "Offer"), which expired at 5:00 p.m. (Toronto Time) on April 2, 2024. Based on the preliminary count by...

Ferguson plc (the "Company") announces today that it purchased a total of 62,209 of its ordinary shares in the period from March 25, 2024, up to and including March 28, 2024, in connection with its $3.0 billion share repurchase program. Aggregated...

Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of a restricted stock unit (RSU) award for 8,400 shares of Syros...

ON Semiconductor Corporation ("onsemi") disclosed today that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation, an Ontario corporation ("TRC Capital Investment"). onsemi is not affiliated or associated...

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to three new employees. The Compensation...

Organigram Holdings Inc. ("Organigram" or the "Company") announces today the closing of its previously announced underwritten public offering of units of the Company (the "Units") for total gross proceeds of C$28,750,230 (the "Offering"). The...

Melt Pharmaceuticals, Inc. ("Melt"), a clinical?stage pharmaceutical company developing novel approaches for procedural sedation, today announced the completion of its Series B Preferred Stock financing of approximately $24 million from new and...

Cannae Holdings, Inc. ("Cannae" or the "Company") today announced preliminary results of its modified "Dutch auction" tender offer (the "Offer") to purchase up to $200 million in aggregate purchase price of its outstanding shares of common stock,...

Matador Resources Company ("Matador") today announced the expiration and results of its previously announced cash tender offer (the "Tender Offer") to purchase any and all of the approximately $699.2 million outstanding aggregate principal amount of...

LENSAR, Inc. ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 1,425 shares of the...

Arrowhead Pharmaceuticals, Inc. today announced that as an inducement to entering into employment with the Company, on March 30, 2024, the Company's Board of Directors approved "inducement" grants to 32 new employees under Rule 5635(c)(4) of the...

DermTech, Inc. ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that effective March 27, 2024, the Compensation Committee of DermTech's Board of Directors granted an...

Guerrilla RF, Inc. ("Guerrilla" or the "Company"), a leading provider of state-of-the-art RF and microwave semiconductors, today announced that it completed a private placement equity financing, selling approximately 2.0 million shares of its common...

Moving iMage Technologies ("MiT"), a leading technology and services company for cinema, Esports, stadiums, arenas and other out-of-home entertainment venues, today announced it has adopted a new share repurchase program to replace the Company's...

Guess?, Inc. (the "Company") announced today that it has entered into a separate, privately negotiated exchange and subscription agreement (the "Exchange and Subscription Agreement") with a holder of its 2.00% convertible senior notes due 2024 (the...

Guess?, Inc. (the "Company") today announced that its Board of Directors has authorized a new share repurchase program of up to $200 million of the Company's common stock. Guess? also separately announced today that, as part of this new program and...

Mitsubishi Electric Corporation (TOKYO: 6503) announced today the conclusion of its repurchase of company stock pursuant to the provisions of Article 459, paragraph 1 of the Companies Act, as well as Article 31 of the company's articles of...

Nidec Corporation (TOKYO:6594; OTC US: NJDCY) (the "Company") today announced the status of the Company's own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 24, 2024, pursuant to...

Incyte announced today that it granted equity inducement awards to Matteo Trotta, the Company's new Executive Vice President and General Manager of U.S. Dermatology, pursuant to the Company's 2024 Inducement Stock Incentive Plan. The awards were...

FuboTV Inc. (d/b/a Fubo) , the leading sports-first live TV streaming platform, today announced that on March 26, 2024, the Compensation Committee of Fubo's Board of Directors granted restricted stock unit awards covering an aggregate of 39,291...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2024 Employment...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...